Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 470

1.

Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection.

Yun JJ, Whiting D, Fischbein MP, Banerji A, Irie Y, Stein D, Fishbein MC, Proudfoot AE, Laks H, Berliner JA, Ardehali A.

Circulation. 2004 Feb 24;109(7):932-7. Epub 2004 Feb 2.

2.

Regulated on activation, normal T cell expressed and secreted (RANTES) antagonist (Met-RANTES) controls the early phase of Trypanosoma cruzi-elicited myocarditis.

Marino AP, da Silva A, dos Santos P, Pinto LM, Gazzinelli RT, Teixeira MM, Lannes-Vieira J.

Circulation. 2004 Sep 14;110(11):1443-9. Epub 2004 Aug 30.

3.

Rantes production during development of cardiac allograft vasculopathy.

Yun JJ, Fischbein MP, Laks H, Irie Y, Espejo ML, Fishbein MC, Berliner JA, Ardehali A.

Transplantation. 2001 Jun 15;71(11):1649-56.

PMID:
11435978
4.

Inhibition of chemokine receptor CCR2 and CCR5 expression contributes to simvastatin-induced attenuation of cardiac allograft vasculopathy.

Yin R, Zhu J, Shao H, Cheng X, Feng X, Li Z, Jing H.

J Heart Lung Transplant. 2007 May;26(5):485-93.

PMID:
17449418
5.
6.

The role of chemokines and their receptors in the rejection of pig islet tissue xenografts.

Solomon MF, Kuziel WA, Mann DA, Simeonovic CJ.

Xenotransplantation. 2003 Mar;10(2):164-77.

PMID:
12588649
7.

Differential role of CCR2 in islet and heart allograft rejection: tissue specificity of chemokine/chemokine receptor function in vivo.

Abdi R, Means TK, Ito T, Smith RN, Najafian N, Jurewicz M, Tchipachvili V, Charo I, Auchincloss H Jr, Sayegh MH, Luster AD.

J Immunol. 2004 Jan 15;172(2):767-75.

8.

Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection.

Morita K, Miura M, Paolone DR, Engeman TM, Kapoor A, Remick DG, Fairchild RL.

J Immunol. 2001 Sep 1;167(5):2979-84.

9.

Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice.

Veillard NR, Kwak B, Pelli G, Mulhaupt F, James RW, Proudfoot AE, Mach F.

Circ Res. 2004 Feb 6;94(2):253-61. Epub 2003 Dec 1.

10.

Treatment of experimental autoimmune encephalomyelitis with the chemokine receptor antagonist Met-RANTES.

Matsui M, Weaver J, Proudfoot AE, Wujek JR, Wei T, Richer E, Trapp BD, Rao A, Ransohoff RM.

J Neuroimmunol. 2002 Jul;128(1-2):16-22.

PMID:
12098506
11.

CD8+ lymphocytes augment chronic rejection in a MHC class II mismatched model.

Fischbein MP, Yun J, Laks H, Irie Y, Fishbein MC, Espejo M, Bonavida B, Ardehali A.

Transplantation. 2001 Apr 27;71(8):1146-53.

PMID:
11374417
12.

A novel small-molecule compound targeting CCR5 and CXCR3 prevents acute and chronic allograft rejection.

Akashi S, Sho M, Kashizuka H, Hamada K, Ikeda N, Kuzumoto Y, Tsurui Y, Nomi T, Mizuno T, Kanehiro H, Hisanaga M, Ko S, Nakajima Y.

Transplantation. 2005 Aug 15;80(3):378-84.

PMID:
16082334
13.

Met-RANTES ameliorates fibrous airway obliteration and decreases ERK expression in a murine model of bronchiolitis obliterans.

Uchida O, Kajiwara N, Hayashi A, Miyajima K, Nagatsuka T, Hayashi H, Taira M, Kimura M, Tsuboi M, Kato H.

Ann Thorac Cardiovasc Surg. 2007 Apr;13(2):82-6.

PMID:
17505414
14.

Early and late chemokine production correlates with cellular recruitment in cardiac allograft vasculopathy.

Yun JJ, Fischbein MP, Laks H, Fishbein MC, Espejo ML, Ebrahimi K, Irie Y, Berliner J, Ardehali A.

Transplantation. 2000 Jun 27;69(12):2515-24.

PMID:
10910271
15.

Antibody-mediated rejection of cardiac allografts in CCR5-deficient recipients.

Nozaki T, Amano H, Bickerstaff A, Orosz CG, Novick AC, Tanabe K, Fairchild RL.

J Immunol. 2007 Oct 15;179(8):5238-45.

16.

Role of CXCR3 and CCR5 in allograft rejection.

Schnickel GT, Hsieh GR, Garcia C, Shefizadeh A, Fishbein MC, Ardehali A.

Transplant Proc. 2006 Dec;38(10):3221-4.

PMID:
17175228
18.

The contribution of chemokines and chemokine receptors to the rejection of fetal proislet allografts.

Solomon MF, Kuziel WA, Simeonovic CJ.

Cell Transplant. 2004;13(5):503-14.

PMID:
15565863
19.

The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.

van Loosdregt J, van Oosterhout MF, Bruggink AH, van Wichen DF, van Kuik J, de Koning E, Baan CC, de Jonge N, Gmelig-Meyling FH, de Weger RA.

Circulation. 2006 Oct 10;114(15):1599-607. Epub 2006 Oct 2.

20.

Inhibition of airway inflammation by amino-terminally modified RANTES/CC chemokine ligand 5 analogues is not mediated through CCR3.

Chvatchko Y, Proudfoot AE, Buser R, Juillard P, Alouani S, Kosco-Vilbois M, Coyle AJ, Nibbs RJ, Graham G, Offord RE, Wells TN.

J Immunol. 2003 Nov 15;171(10):5498-506.

Supplemental Content

Support Center